Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 33,421 | reported | 19 Mar 2026 | tx 113+1,290,150−733,303 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 11,964 | 67.00 USD | |
| 18 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 11,667 | 68.71 USD | |
| 17 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 10,972 | 69.42 USD | |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 66,274 | — | |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 11,300 | 0.00 USD | deriv |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 16,975 | 0.00 USD | deriv |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 23,121 | 0.00 USD | deriv |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 14,878 | 0.00 USD | deriv |
| 05 Mar 2026 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 60,776 | 0.00 USD | deriv |
| 05 Mar 2026 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 96,723 | 0.00 USD | deriv |
| 24 Dec 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 5,443 | 82.41 USD | |
| 24 Dec 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 557 | 83.54 USD | |
| 04 Dec 2025 | GIFT | Tarsus Pharmaceuticals, Inc. | 51,885 | 0.00 USD | |
| 24 Sept 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 6,000 | 55.37 USD | |
| 11 Aug 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 6,000 | 50.00 USD | |
| 24 Mar 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 6,000 | 50.00 USD | |
| 19 Mar 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 8,551 | 47.40 USD | |
| 20 Mar 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 8,534 | 50.11 USD | |
| 18 Mar 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 7,131 | 46.29 USD | |
| 15 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 51,395 | — | |
| 15 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 16,975 | 0.00 USD | deriv |
| 15 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 23,121 | 0.00 USD | deriv |
| 15 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 11,299 | 0.00 USD | deriv |
| 05 Mar 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 90,736 | 0.00 USD | deriv |
| 05 Mar 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 59,512 | 0.00 USD | deriv |